Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

Postow Michael A.; Chesney Jason; Pavlick Anna C.; Robert Caroline; Grossmann Kenneth; McDermott David; Linette Gerald P.; Meyer Nicolas; Giguere Jeffrey K.; Agarwala Sanjiv S.; Shaheen Montaser; Ernstoff Marc S.; Minor David; Salama April K.; Taylor Matthew; Ott Patrick A.; Rollin Linda M.; Horak Christine; Gagnier Paul; Wolchok Jedd D.; Hodi F. Stephen

首页> 外文期刊>The New England journal of medicine >Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

【24h】

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

机译：Nivolumab和Ipilimumab与未经治疗的黑色素瘤的IpiLimumab

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND

机译：背景

著录项

来源
《The New England journal of medicine》 |2015年第21期|共12页
作者
Postow Michael A.; Chesney Jason; Pavlick Anna C.; Robert Caroline; Grossmann Kenneth; McDermott David; Linette Gerald P.; Meyer Nicolas; Giguere Jeffrey K.; Agarwala Sanjiv S.; Shaheen Montaser; Ernstoff Marc S.; Minor David; Salama April K.; Taylor Matthew; Ott Patrick A.; Rollin Linda M.; Horak Christine; Gagnier Paul; Wolchok Jedd D.; Hodi F. Stephen;
展开▼
作者单位

NYU Mem Sloan Kettering Canc Ctr New York NY USA;

Univ Louisville James Graham Brown Canc Ctr Louisville KY 40292 USA;

NYU Perlmutter Canc Ctr New York NY USA;

Inst Gustave Roussy Villejuif France;

Huntsman Canc Inst Salt Lake City UT USA;

Beth Israel Deaconess Med Ctr Boston MA 02215 USA;

Washington Univ St Louis MO USA;

Inst Univ Canc Toulouse France;

Greenville Hlth Syst Greenville SC USA;

St Lukes Canc Ctr Bethlehem PA USA;

Univ New Mexico Albuquerque NM 87131 USA;

Cleveland Clin Fdn Taussig Canc Inst Cleveland OH 44195 USA;

Calif Pacific Ctr Melanoma Res San Francisco CA USA;

Duke Univ Durham NC USA;

Oregon Hlth &

Sci Univ Portland OR 97201 USA;

Dana Farber Canc Inst Boston MA 02215 USA;

Bristol Myers Squibb Co Wallingford CT 06492 USA;

Bristol Myers Squibb Co Lawrenceville NJ USA;

Bristol Myers Squibb Co Wallingford CT 06492 USA;

NYU Mem Sloan Kettering Canc Ctr New York NY USA;

Dana Farber Canc Inst Boston MA 02215 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类 R23;
关键词

相似文献

外文文献
中文文献
专利

1. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma (vol 373, pg 2006, 2015) [J] . Melero Ignacio, Lasarte Juan J. The New England journal of medicine . 2018,第22期

机译：Nivolumab和Ipilimumab与Ipilemimab在未经治疗的黑色素瘤中（Vol 373，PG 2006,2015）
2. Quality-adjusted survival of nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone among treatment-naive patients with advanced melanoma: a quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis [J] . McDermott David F., Shah Ruchit, Gupte-Singh Komal, Quality of life research: An international journal of quality of life aspects of treatment, care and rehabilitation . 2019,第1期

机译：单独调整Nivolumab Plus Ipilemimab或Nivolumab的质量调整的存活率，单独使用高级黑素瘤的治疗野生患者：一种没有症状或毒性的质量调整时间（q-twist）分析
3. Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma [J] . Ravi Potluri, Sandip Ranjan, Hitesh Bhandari, Experimental Hematology Oncology . 2019,第1期

机译：Nivolumab与Ipilimumab与Nivolumab单药治疗和Ipilemimab单药治疗晚期黑色素瘤的医疗成本比较分析
4. SOD Comparison of Untreated versus CHPand Permanganate-Treated Soil [C] . Stan Haskins, Pat Haldemanm, Mark Ungar International Conference on Remediation of Chlorinated adn Recalcitrant Compounds . 2010

机译：未经处理的SOD比较与CHPAND高锰酸盐处理的土壤
5. Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study [D] . Kobayashi Tomoko, 小林朋子 2019

机译：抗甲状腺抗体的患者通过Nivolumab容易发展为破坏性甲状腺炎：一项前瞻性研究
6. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma [O] . Michael A. Postow, Jason Chesney, Anna C. Pavlick, -1

机译：Nivolumab和Ipilimumab与Ipilimumab在未经治疗的黑色素瘤中的作用
7. PCN91 HEALTHCARE COST COMPARISON ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB VERSUS NIVOLUMAB MONOTHERAPY AND IPILIMUMAB MONOTHERAPY IN ADVANCED MELANOMA [O] . R. Potluri, H. Bhandari, S. Ranjan, 2019

机译：Nivolumab与IpiLimumab与Nivolumab单药治疗和Ipilimalab单药治疗晚期黑素瘤的PCN91医疗成本比较分析

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

摘要

著录项

相似文献

相关主题

期刊订阅